Belgium

 

Healthcare real estate investors break barriers

The internationalisation of healthcare real estate is gathering pace, according to all the signs at MIPIM, the world’s largest property conference. Numerous investors told Healthcare Europa they were looking beyond their core markets. This follows recent foreign ventures by the healthcare REITs Aedifica, Cofinimmo, Primary Health Properties (PHP) and Medical Properties Trust (MPT). We look at why.
March 21, 2016

Turkish ophthalmology chain targets Ghana as part of $50m investment

Turkish ophthalmology chain Batigoz Health Group, which already has clinics in several European contries, is planning to strengthen its presence in a $50m expansion. The group says it is about to receive private equity funding from a major Gulf investor and that it aims to reach Ghana by 2017. It also targets medical tourism. We speak to CEO Pinar Massena.
March 21, 2016

Confinimmo spends €60m in Germany and the Netherlands

Belgian REIT Cofinimmo, which owns a portfolio worth over €3.3bn, has bought several medical offices in the Netherlands for €29.5m with yields ranging between 7% and 8.3%. Earlier this week, it also acquired the Kaiser Karl rehabilitation clinic in Bonn, Germany for €30m as well, to be rented to 800-bed German operator Eifelhöhen-Klinik AG under a 25-year double net lease, for an initial yield of 7.32%.
December 18, 2015

Report: Reforming healthcare – trends and trajectories

European countries are undergoing rapid and substantial demographic and technological changes. Yet, healthcare systems are still mainly state-funded and acute-focused, as they have been for the past 70 years. This is starting to change.
November 4, 2015

The mating endgame at Unilabs

We hear that Labcorp, the big US lab group is the latest potential bidder to kick the types at Unilabs, the Pan-West European lab group which Rothschild has put on the block. We analyse the bidders in an endgame of consolidation.
October 26, 2015

Report: Healthcare Europa Property Survey 2015

There is intense investor interest in healthcare services property across Europe. Fund manager Marc Phillip Martins-Kuenzel, at German real estate investor Corpus Sireo claims that he had 400 approaches from prospective buyers in a single year. This reflects the global search for high yielding investments. But healthcare property also carries risks. Some sectors such as the French hospital market, where major deals have been done, look risky as the government cuts tariffs. And the sector remains opaque and poorly segmented. There are plenty of traps for the unwary. It is also far from clear how much new capacity will come on stream for investors over the next decade. Here we look at whether and when the boom will go bust. First, we run through the headlines and what has happened to prices. We then go on to look at supply and demand. Other articles profile the main US and European property investors and the main national markets.
October 2, 2015

Mediq continues homecare buy and build

Dutch distributor and medicialised homecare operator Mediq has completed its acquisition of Frankfurt-based Reininger. It is looking for more deals in the countries where it already has a presence: Belgium, France, Germany, Switzerland, Hungary, the Nordics, the Baltics, the Netherlands and, more recently, the United States.
September 18, 2015

Antin buys amedes as doctors walk

Antin Infrastructure Partners has bought General Atlantic’s majority stake in amedes, the big German lab and gynaecology specialist. This is not just Antin’s first healthcare service investment, but also its first investment in a people business. It could be a steep learning curve – we hear that many doctors are quitting amedes. We talk to amedes about future plans and the consolidation of the German outpatient sector.
July 13, 2015

Cinven’s €3 billion bet on labs

Cinven has placed a €3bn bet on the European diagnostic laboratory space, by agreeing to pay a higher than expected €1.85bn for synlab Group, a multiple of just over 12 times current EBITDA. It will combine synlab with Labco to create a truly Pan-European lab group with pro-forma 2014 sales of just over €1.4bn, nearly twice that of its nearest rival. But why bet €3bn on a sector where tariffs are falling and operators have no control over pricing? And could the French authorities block the deal?
June 26, 2015

Cofinimmo increases its German footprint

Belgian healthcare real estate investment trust Cofinimmo has tripled its investments in Germany with the purchase and leaseback of two high-end wellness and sport centres from the Aspria Group. We speak to Cofinimmo CEO, Jean-Edouard Carbonnelle about the deal.
June 11, 2015
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us